Bendamustin in combination with Fludarabin for the treatment of refractory or relapsed low-grade lymphoma - A multicenter phase I/II trial of the East German study group for hematology and oncology (OSHO).

被引：0
|
作者：
Koenigsmann, MP [1 ]
Knauf, WU [1 ]
Herold, M [1 ]
Franke, A [1 ]
机构：
[1] Otto Von Guericke Univ, Magdeburg, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2543
引用
收藏
页码：607A / 607A
页数：1
相关论文
共 50 条
  • [1] Fludarabine and bendamustine in refractory and relapsed indolent lymphoma -: a multicenter phase I/II trial of the East German society of Hematology and Oncology (OSHO)
    Koenigsmann, M
    Knauf, WU
    Herold, M
    Pasold, R
    Müller, G
    Eschenburg, H
    Kahl, C
    Lakner, V
    Assmann, M
    Jentsch-Ullrich, K
    Mohren, M
    Bartsch, R
    Franke, A
    LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1821 - 1827
  • [2] Bendamustin (B) and rituximab (R) in the treatment of relapsed indolent CD 20+ non-Hodgkin-lymphoma - A phase II study of The East German Study Group of haematology and oncology (OSHO # 072)
    Lakner, V.
    Eschenburg, H.
    Aldaoud, A.
    Uhlig, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 209 - 210
  • [3] BENDAMUSTIN (B) AND RITUXIMAB (R) IN THE TREATMENT OF RELAPSED INDOLENT CD20+ NON-HODGKIN-LYMPHOMA - A PHASE II STUDY OF THE EAST GERMAN STUDY GROUP OF HAEMATOLOGY AND ONCOLOGY (OSHO #072)
    Lakner, V.
    Eschenburg, H.
    Schwarzer, A.
    Uhlig, J.
    Mohren, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 186 - 187
  • [4] Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group
    Scheubeck, Gabriel
    Hoffmann, Martin
    Jurinovic, Vindi
    Fischer, Luca
    Unterhalt, Michael
    Schmidt, Christian
    Boeck, Hans-Peter
    Duehrsen, Ulrich
    Kaesberger, Joachim
    Kremers, Stephan
    Lindemann, Hans-Walter
    Mantovani, Luisa
    Hiddemann, Wolfgang
    Hoster, Eva
    Dreyling, Martin
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2373 - 2380
  • [5] FLUDARABINE IN RELAPSED LOW-GRADE NON-HODGKIN LYMPHOMAS - A PHASE-II STUDY OF THE GERMAN LOW-GRADE LYMPHOMA STUDY-GROUP
    POTT, C
    UNTERHALT, M
    SANDFORD, D
    MARKERT, H
    FREUND, M
    ENGERT, A
    GASSMANN, W
    HOLTKAMP, W
    SEUFERT, M
    HELLRIEGEL, K
    KNAUF, B
    NIEBERDING, R
    EMMERICH, B
    KOCH, P
    WORMANN, B
    HIDDEMANN, W
    BLOOD, 1993, 82 (10) : A575 - A575
  • [6] Fludarabine in combination with idarubicin as treatment of untreated and relapsed low-grade lymphoma. Preliminary results of a multicenter phase II study.
    Kimby, E
    Cavallin-Stahl, E
    Haapaniemi, E
    Hagberg, H
    Osterman, B
    Tullgren, O
    Turesson, I
    Liliemark, J
    BLOOD, 1999, 94 (10) : 95A - 95A
  • [7] A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-hodgkin lymphoma
    Larson, BJG
    Waples, JM
    Pusateri, A
    Mendenhall, NP
    Lynch, JW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (02): : 165 - 168
  • [8] BOP versus COP in advanced indolent lymphomas - Results of a randomized multicenter phase III study of the East German Study Group Hematology/Oncology (OSHO).
    Herold, M
    Schulze, A
    Niederwieser, D
    Franke, A
    Fricke, HJ
    Richter, P
    Freund, M
    Ismer, B
    Dachselt, M
    Boewer, C
    Schirmer, V
    Weniger, J
    Pasold, R
    Winkelmann, B
    Klinkenstein, C
    Schulze, M
    Arzberger, A
    Bremer, K
    Hahnfeld, S
    Mueller, C
    Mueller, C
    BLOOD, 2002, 100 (11) : 779A - 779A
  • [9] A phase II study of arsenic trioxide in the treatment of relapsed and refractory low-grade lymphomas.
    Furman, RR
    Sirulnik, A
    Kamalu, OO
    Brenner, RB
    Paciucci, PA
    Gabrilove, JL
    Waxman, S
    BLOOD, 2002, 100 (11) : 304B - 304B
  • [10] Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma.
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Simon, SR
    Weinstein, RE
    BLOOD, 2000, 96 (11) : 236B - 236B
12345